NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/21/2026
Back to search
Official data from USPTO
PERIGON PHARMACY THREE SIXTY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
PERIGON PHARMACY THREE SIXTY
ST13
US500000098445795Class
5
Filing
98445795
Registration
8356664
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
29
Latest update
08/03/2026
Trademark type
Word
Nice classes
5
Filing date
03/12/2024
Registration date
07/21/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/21/2026
Last transaction
08/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
06/07/2021
First use in commerce
06/07/2021
Drawing code
4
Owner type
16
Owner location
Plymouth, MI, US
Examiner
HINES, REGINA C
Law office
M50
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Tespo Health Holdings LLC
Representatives
James M. Theo Dinsmore & Shohl LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Prescription and non-prescription medicinespillstabletscapsulescapletsliquid dropssachets and pharmaceutical preparations for the treatment of rare and chronic health conditions.
Publications
History of USPTO decisions and trademark events.
29 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
07/21/2026
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
07/01/2026
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
07/01/2026
SUPC
STATEMENT OF USE PROCESSING COMPLETE
06/02/2026
IUAF
USE AMENDMENT FILED
02/11/2026
EISU
TEAS STATEMENT OF USE RECEIVED
02/11/2026
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
09/16/2025
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
08/10/2025
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
04/29/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/01/2025
PUBO
PUBLISHED FOR OPPOSITION
04/01/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/26/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/07/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/05/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/05/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/05/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/13/2024
GNRT
NON-FINAL ACTION E-MAILED
12/13/2024
CNRT
NON-FINAL ACTION WRITTEN
12/13/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/31/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/31/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/31/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/30/2024
GNRT
NON-FINAL ACTION E-MAILED
09/30/2024
CNRT
NON-FINAL ACTION WRITTEN
09/30/2024
DOCK
ASSIGNED TO EXAMINER
09/23/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/12/2024
NWAP
NEW APPLICATION ENTERED
03/12/2024
Continuous trademark protection
Get notified about every new filing that threatens PERIGON PHARMACY THREE SIXTY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.